+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Veterinary Antibiotics Market Size, Share & Trends Analysis Report by Animal Type (Pigs, Cattle), Dosage Form (Oral Powders, Injections), Drug Class, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 258 Pages
  • June 2024
  • Region: Global
  • Grand View Research
  • ID: 5983048
Description Jump to:
The global veterinary antibiotics market size is expected to reach USD 6.29 billion by 2030, registering a CAGR of 3.10% from 2024 to 2030. The primary drivers of market growth include a rising focus on animal-only antibiotics and ionophores, growing initiatives by key companies and the launch of new products, and the increasing incidence of livestock diseases. Key players are significantly launching new antibiotics to meet the demand, as some of the older antibiotics have been associated with resistance. For instance, in January 2023, Norbrook launched Tulieve, a generic tulathromycin injection for treating bacterial infections in beef cattle, nonlactating dairy cattle, and swine.

Similarly, in December 2021, Virbac launched Tulissin, an antibiotic solution for swine and cattle with respiratory pathologies. These products were made available for European veterinarians. Therefore, R&D and manufacturing for antibiotic development are ongoing, which is anticipated to continue without a complete halt anytime soon. This factor is contributing to the market growth.

One of the opportunities to further accelerate market growth in the future is the discovery of novel antibiotics. There is a continuous need for new antibiotics to combat emerging resistant strains in veterinary medicine. Research and development in this area could lead to breakthrough drugs that address unmet needs in treating animal infections. According to the U.S. Department of Agriculture, the development of innovative drugs could reduce resistance and the need for existing antibiotics in the production of food animals. Moreover, the need for medications intended for companion animals may promote the development of novel products for that market rather than for use in food animals. On the other hand, increasing export demand for U.S. meat is intensifying animal illness challenges caused by globalization, and the development of antibiotic resistance in animals could boost the demand for antibiotics and the development of new antibiotics.

Moreover, major veterinary antibiotic manufacturers are facing severe competition from generic drug developers globally. These generic products also create pricing pressure on manufacturers owing to their cost-effectiveness. As the patent for antibiotic products expires, generic drug developers introduce alternative forms of products into the market. For instance, Elanco’s Maxiban (an ionophore/animal-only antibiotic) has no patent protection as of 2021, thus, competitors might begin to develop generic & lower-priced alternatives. Similarly, Zoetis reported in 2021 that the company faces competition from generic product developers once a product’s patent expires. As a result, the company has been compelled to reduce its prices and provide discounts for major products to compete with the lower-priced alternative generic products available in the market. Therefore, increasing generic competition is expected to create challenges in the market in the long run.

In addition, the rising awareness of livestock diseases is predicted to create a demand for veterinary treatment in hospitals & clinics, creating a requirement for veterinary antibiotics. For instance, Ontario has approximately 5,247 veterinarians, followed by 1,650 in British Columbia. Furthermore, antibiotics used for livestock treatment must meet Health Canada’s human & animal safety standards. Veterinarians can choose from various antibiotics designed to help prevent or lower the severity of diseases that threaten animals. Every antibiotic marketed in the country must be licensed by the Canadian Food Inspection Agency. Such factors are likely to propel market growth.

Veterinary Antibiotics Market Report Highlights

  • Based on animal type, the cattle segment held the largest share of 39.63% in 2023. Increased consumption of beef and dairy products is a major factor expected to drive the segment.
  • Based on drug class, the tetracyclines segment dominated the market with a share of 28.93% in 2023. Tetracyclines are a class of commonly used veterinary antibiotics.
  • The oral solutions segment dominated the market with a share of 50.20% in 2023. Oral liquids or solutions are among the easiest dosage forms of veterinary antibiotics to develop and use.
  • North America dominated the global market with a share of 32.49% in 2023. This regional market is likely to be driven by the presence of established players and increasing demand for treatment among veterinary practices.
  • Asia Pacific is anticipated to grow at the fastest CAGR of 4.10% over the forecast period.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Veterinary Antibiotics Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising focus on animal-only antibiotics and ionophores
3.2.1.2. Growing Initiatives by key companies And launch of new products
3.2.1.3. Increasing Incidence of Livestock Diseases
3.2.2. Market Restraint Analysis
3.2.2.1. Stringent regulations
3.2.2.2. Decline In the use of antibiotics
3.2.2.3. Rising research on antibiotic alternatives
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Veterinary Antibiotics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.3. Regulatory Framework
3.3.4. Patent-Off Dates Analysis for Major Veterinary Antibiotics
3.3.5. Product Pipeline Analysis
3.3.6. Overall Estimated Sales Of Antimicrobial VMPs (Active Substance) In Tonnes By European Country, 2023
3.3.7. Estimated Sales Of Antimicrobial Active Substances in Production Animals in Europe, By Antimicrobial Class, 2023
3.3.8. COVID-19 Impact Analysis
Chapter 4. Veterinary Antibiotics Market: Animal Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Veterinary Antibiotics Market: Animal type Movement Analysis
4.3. Veterinary Antibiotics Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
4.4. Cattle
4.4.1. Cattle Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Pigs
4.5.1. Pigs Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.6. Sheep & Goat
4.6.1. Sheep & Goat Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.7. Poultry
4.7.1. Poultry Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.8. Others
4.8.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Veterinary Antibiotics Market: By Drug Class Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Veterinary Antibiotics Market: By Drug Class Movement Analysis
5.3. Veterinary Antibiotics Market Size & Trend Analysis, by drug class, 2018 to 2030 (USD Million)
5.3.1. Tetracyclines
5.3.1.1. Tetracyclines Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.2. Penicillins
5.3.2.1. Penicillins Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.3. Sulfonamides
5.3.3.1. Sulfonamides Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.4. Penicillins
5.3.4.1. Penicillins Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.5. Macrolides
5.3.5.1. Macrolides Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.6. Trimethoprim
5.3.6.1. Trimethoprim Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.7. Lincosamides
5.3.7.1. Lincosamides Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.8. Polymyxins
5.3.8.1. Polymyxins Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.9. Aminoglycosides
5.3.9.1. Aminoglycosides Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.10. Fluoroquinolones
5.3.10.1. Fluoroquinolones Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.11. Pleuromutilins
5.3.11.1. Pleuromutilins Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.12. Others
5.3.12.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Veterinary Antibiotics Market: By Dosage Form Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Veterinary Antibiotics Market: By Dosage Form Movement Analysis
6.3. Veterinary Antibiotics Market Size & Trend Analysis, by dosage form, 2018 to 2030 (USD Million)
6.3.1. Oral Powders
6.3.1.1. Oral powders Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.3.2. Oral solutions
6.3.2.1. Oral solutions Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.3.3. Injections
6.3.3.1. Injections Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.3.4. Others
6.3.4.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Veterinary Antibiotics Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Veterinary Antibiotics Market Share, By Region, 2023 & 2030 (USD Million)
7.3. Regional Outlook
7.4. North America
7.4.1. North America Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. U.S. Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Canada Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5. Europe
7.5.1. Europe Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. UK Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Germany Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. France Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Italy Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Spain Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Denmark Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Sweden Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Norway Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.10. Belgium
7.5.10.1. Key Country Dynamics
7.5.10.2. Belgium Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.11. Hungary
7.5.11.1. Key Country Dynamics
7.5.11.2. Hungary Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.12. Poland
7.5.12.1. Key Country Dynamics
7.5.12.2. Poland Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.13. Portugal
7.5.13.1. Key Country Dynamics
7.5.13.2. Portugal Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.14. Romania
7.5.14.1. Key Country Dynamics
7.5.14.2. Romania Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.15. Netherlands
7.5.15.1. Key Country Dynamics
7.5.15.2. Romania Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Japan Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. China Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. India Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6.5. Australia
7.6.5.1. Key Country Dynamics
7.6.5.2. Australia Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. South Korea Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Brazil Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.7.3. Mexico
7.7.3.1. Key Country Dynamics
7.7.3.2. Mexico Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.7.4. Argentina
7.7.4.1. Key Country Dynamics
7.7.4.2. Argentina Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.8. Middle East & Africa
7.8.1. Middle East & Africa Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. South Africa Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Saudi Arabia Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. UAE Veterinary Antibiotics Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Company Market Position Analysis/ Heap Map Analysis
8.3. Company Profiles
8.3.1. Merck & Co., Inc.
8.3.1.1. Participant’s Overview
8.3.1.2. Financial Performance
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Ceva Santé Animale.
8.3.2.1. Participant’s Overview
8.3.2.2. Financial Performance
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Vetoquinol
8.3.3.1. Participant’s Overview
8.3.3.2. Financial Performance
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Zoetis Services LLC
8.3.4.1. Participant’s Overview
8.3.4.2. Financial Performance
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Boehringer Ingelheim International GmbH
8.3.5.1. Participant’s Overview
8.3.5.2. Financial Performance
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Dechra Pharmaceuticals PLC
8.3.6.1. Participant’s Overview
8.3.6.2. Financial Performance
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Elanco Animal Health Incorporated
8.3.7.1. Participant’s Overview
8.3.7.2. Financial Performance
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Virbac S.A.
8.3.8.1. Participant’s Overview
8.3.8.2. Financial Performance
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Calier.
8.3.9.1. Participant’s Overview
8.3.9.2. Financial Performance
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Bimeda, Inc
8.3.10.1. Participant’s Overview
8.3.10.2. Financial Performance
8.3.10.3. Product Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. Prodivet pharmaceuticals SA/NV
8.3.11.1. Participant’s Overview
8.3.11.2. Financial Performance
8.3.11.3. Product Benchmarking
8.3.11.4. Strategic Initiatives
8.3.12. Norbrook Laboratories
8.3.12.1. Participant’s Overview
8.3.12.2. Financial Performance
8.3.12.3. Product Benchmarking
8.3.12.4. Strategic Initiatives
8.4. Strategy Mapping
8.4.1. Mergers & Acquisitions
8.4.2. Partnerships & Collaborations
8.4.3. Expansion
8.4.4. Product launch
8.4.5. Product Approval
8.4.6. Others
8.5. List of Key Companies
8.5.1. List of Manufacturers
8.5.2. List of Distributors
List of Tables
Table 1 List of secondary sources
Table 2 Veterinary Antibiotics market, by region, 2018-2030 (USD Million)
Table 3 Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 4 Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 5 Veterinary Antibiotics market, by By Dosage Form, 2018-2030 (USD Million)
Table 6 North America Veterinary Antibiotics market, by country, 2018-2030 (USD Million)
Table 7 North America Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 8 North America Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 9 North America Veterinary Antibiotics market, by By Dosage Form, 2018-2030 (USD Million)
Table 10 U.S. Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 11 U.S. Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 12 U.S. Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 13 Canada Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 14 Canada Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 15 Canada Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 16 Europe Veterinary Antibiotics market, by country, 2018-2030 (USD Million)
Table 17 Europe Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 18 Europe Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 19 Europe Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 20 Germany Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 21 Germany Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 22 Germany Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 23 UK Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 24 UK Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 25 UK Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 26 France Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 27 France Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 28 France Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 29 Italy Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 30 Italy Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 31 Italy Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 32 Spain Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 33 Spain Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 34 Spain Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 35 Denmark Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 36 Denmark Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 37 Denmark Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 38 Sweden Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 39 Sweden Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 40 Sweden Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 41 Norway Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 42 Norway Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 43 Norway Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 44 Netherlands Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 45 Netherlands Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 46 Netherlands Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 47 Belgium Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 48 Belgium Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 49 Belgium Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 50 Portugal Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 51 Portugal Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 52 Portugal Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 53 Hungary Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 54 Hungary Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 55 Hungary Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 56 Poland Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 57 Poland Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 58 Poland Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 59 Romania Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 60 Romania Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 61 Romania Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 62 Asia Pacific Veterinary Antibiotics market, by country, 2018-2030 (USD Million)
Table 63 Asia Pacific Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 64 Asia Pacific Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 65 Asia Pacific Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 66 China Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 67 China Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 68 China Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 69 Japan Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 70 Japan Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 71 Japan Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 72 India Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 73 India Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 74 India Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 75 South Korea Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 76 South Korea Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 77 South Korea Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 78 Australia Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 79 Australia Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 80 Australia Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 81 Latin America Veterinary Antibiotics market, by country, 2018-2030 (USD Million)
Table 82 Latin America Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 83 Latin America Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 84 Latin America Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 85 Brazil Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 86 Brazil Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 87 Brazil Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 88 Mexico Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 89 Mexico Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 90 Mexico Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 91 Argentina Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 92 Argentina Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 93 Argentina Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 94 MEA Veterinary Antibiotics market, by country, 2018-2030 (USD Million)
Table 95 MEA Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 96 MEA Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 97 MEA Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 98 South Africa Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 99 South Africa Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 100 South Africa Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 101 Saudi Arabia Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 102 Saudi Arabia Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 103 Saudi Arabia Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 104 UAE Veterinary Antibiotics market, by Animal type, 2018-2030 (USD Million)
Table 105 UAE Veterinary Antibiotics market, by Drug class, 2018-2030 (USD Million)
Table 106 UAE Veterinary Antibiotics market, by Dosage Form, 2018-2030 (USD Million)
Table 107 Company Overview
Table 108 Product Benchmarking
Table 109 Financial Performance
Table 110 Strategic Initiatives
List of Figures
Figure 1 Market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Veterinary Antibiotics Market revenue, 2018-2030 (USD Million)
Figure 10 Veterinary Antibiotics Market snapshot
Figure 11 Veterinary Antibiotics Market driver impact
Figure 12 Veterinary Antibiotics Market restraint impact
Figure 13 Veterinary Antibiotics animal type key takeaways (USD Million)
Figure 14 Veterinary Antibiotics market: animal Type movement analysis
Figure 15 cattle market, 2018-2030 (USD Million)
Figure 16 pigs market, 2018-2030 (USD Million)
Figure 17 Sheep & Goat market, 2018-2030 (USD Million)
Figure 18 poultry market, 2018-2030 (USD Million)
Figure 19 others market, 2018-2030 (USD Million)
Figure 20 Veterinary Antibiotics Market Drug class key takeaways (USD Million)
Figure 21 Veterinary Antibiotics market: Drug class movement analysis
Figure 22 Tetracyclines market, 2018-2030 (USD Million)
Figure 23 Penicillins market, 2018-2030 (USD Million)
Figure 24 Sulfonamides market, 2018-2030 (USD Million)
Figure 25 Macrolides market, 2018-2030 (USD Million)
Figure 26 Trimethoprim market, 2018-2030 (USD Million)
Figure 27 Lincosamides market, 2018-2030 (USD Million)
Figure 28 Polymyxins market, 2018-2030 (USD Million)
Figure 29 Aminoglycosides market, 2018-2030 (USD Million)
Figure 30 Fluoroquinolones market, 2018-2030 (USD Million)
Figure 31 Pleuromutilins market, 2018-2030 (USD Million)
Figure 32 Others market, 2018-2030 (USD Million)
Figure 33 Veterinary Antibiotics Market by Dosage Form key takeaways (USD Million)
Figure 34 Veterinary Antibiotics market: by Dosage Form movement analysis
Figure 35 Oral powders market, 2018-2030 (USD Million)
Figure 36 Oral Solutions, 2018-2030 (USD Million)
Figure 37 Injections market, 2018-2030 (USD Million)
Figure 38 Others market, 2018-2030 (USD Million)
Figure 39 Regional market place: Key takeaways
Figure 40 Regional outlook, 2023 & 2030
Figure 41 North America Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 42 U.S. Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 43 Canada Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 44 Europe Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 45 UK Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 46 Germany Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 47 France Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 48 Italy Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 49 Spain companion animal Health market, 2018-2030 (USD Million)
Figure 50 Denmark Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 51 Sweden Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 52 Norway Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 53 Netherlands companion animal Health market, 2018-2030 (USD Million)
Figure 54 Belgium companion animal Health market, 2018-2030 (USD Million)
Figure 55 Hungary companion animal Health market, 2018-2030 (USD Million)
Figure 56 Poland companion animal Health market, 2018-2030 (USD Million)
Figure 57 Portugal companion animal Health market, 2018-2030 (USD Million)
Figure 58 Romania companion animal Health market, 2018-2030 (USD Million)
Figure 59 Asia Pacific Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 60 Japan Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 61 China Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 62 India Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 63 Australia Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 64 South Korea Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 65 Latin America Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 66 Brazil Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 67 Mexico Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 68 Argentina Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 69 MEA Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 70 South Africa Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 71 Saudi Arabia Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 72 UAE Veterinary Antibiotics market, 2018-2030 (USD Million)
Figure 73 Market participant categorization

Companies Mentioned

  • Merck & Co., Inc.
  • Ceva Santé Animale.
  • Vetoquinol
  • Zoetis Services LLC
  • Boehringer Ingelheim International GmbH
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Virbac S.A.
  • Calier.
  • Bimeda, Inc
  • Prodivet pharmaceuticals SA/NV
  • Norbrook Laboratories

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages258
PublishedJune 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 5.07 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.29 Billion
Compound Annual Growth Rate3.1%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Global Veterinary Pharmaceuticals Market by Product (Veterinary Antibiotics, Veterinary Parasiticides, Veterinary Vaccines), Vaccines (Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines), Antibiotics, End User, Animal - Forecast 2024-2030 - Product Image

Global Veterinary Pharmaceuticals Market by Product (Veterinary Antibiotics, Veterinary Parasiticides, Veterinary Vaccines), Vaccines (Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines), Antibiotics, End User, Animal - Forecast 2024-2030

  • Report
  • 190 Pages
  • Global
From
Veterinary Antibiotics Global Market Report 2024 - Product Image

Veterinary Antibiotics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Veterinary Antibiotics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Veterinary Antibiotics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 86 Pages
  • Global
From
2024 Global Forecast for Veterinary Antibiotic Preparations, Tetracyclines, and Other Antibiotics (2025-2030 Outlook) - Manufacturing & Markets Report - Product Image

2024 Global Forecast for Veterinary Antibiotic Preparations, Tetracyclines, and Other Antibiotics (2025-2030 Outlook) - Manufacturing & Markets Report

  • Report
  • 132 Pages
  • Global
From
2024 Global Forecast for Veterinary Antibiotic Preparations, Penicillins (2025-2030 Outlook) - Manufacturing & Markets Report - Product Image

2024 Global Forecast for Veterinary Antibiotic Preparations, Penicillins (2025-2030 Outlook) - Manufacturing & Markets Report

  • Report
  • 132 Pages
  • Global
From

About the Veterinary Antibiotics Market

The Veterinary Antibiotics market is a segment of the Animal Healthcare/Veterinary industry that focuses on the production and distribution of antibiotics for use in animals. Veterinary antibiotics are used to treat a variety of bacterial infections in animals, including respiratory, gastrointestinal, and urinary tract infections. They are also used to prevent and control the spread of infectious diseases in animals. Veterinary antibiotics are available in a variety of forms, including tablets, capsules, liquids, and injectables. Veterinary antibiotics are regulated by the Food and Drug Administration (FDA) and must meet certain safety and efficacy standards. Veterinary antibiotics are typically prescribed by veterinarians and dispensed by pharmacies. In some cases, they may be available over-the-counter. Some companies in the Veterinary Antibiotics market include Bayer, Merck, Zoetis, Elanco, and Boehringer Ingelheim. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.